首页 > 最新文献

Journal of Intensive Care Medicine最新文献

英文 中文
Plasma Adsorption with the MTx.100 Column in Critically Ill COVID-19 Patients: A Prospective Study and Propensity Score Analysis 重症 COVID-19 患者使用 MTx.100 柱进行血浆吸附:前瞻性研究和倾向得分分析
IF 3.1 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-09-14 DOI: 10.1177/08850666241280031
Christopher Choi, Nicole De Simone, Christopher B. Webb, Peiman Lahsaei, Sean G. Yates, Jay S. Raval, Michelle S. Harkins, Donald J. Hillebrand, Antonio Belli, Nicolas A. Schlapobersky, Tina S. Ipe, Grace C. Banez-Sese, Vikramjit S. Khangoora, Steven D. Nathan, Trudy M. Demko, David C. Young, Sigalit Caron, Ravi Sarode
BackgroundEarly in the COVID-19 pandemic, patients with severe disease admitted to the intensive care unit (ICU) had a high incidence of mortality. We aimed to investigate whether plasma adsorption with the MTx.100 Column could improve survival.MethodsWe performed a prospective, single-arm, multicenter, Emergency Use Authorization (EUA) trial in patients admitted to the ICU with severe COVID-19 who were worsening despite standard therapy. The primary outcome was all-cause mortality on day 28. Outcomes were analyzed using both a pre-specified performance goal (PG), and a propensity score-matched (PSM) analysis from the highest enrolling center, in which patients treated with the standard of care (SOC) plus the MTx.100 Column (n = 70) were compared to a contemporaneous cohort treated at the same center with SOC only (n = 244).FindingsBetween May 21, 2020, and November 2, 2021, 107 patients with severe COVID-19 (mean age 58.1) at 7 US centers were enrolled and had at least one plasma adsorption treatment initiated. All-cause mortality on day 28 was 37.4% (40/107), an improvement over the prespecified PG (88.1%, p < 0.0001). There were no serious adverse events attributable to the MTx.100 Column or plasmapheresis. Improvements in most metabolic and inflammatory markers were also noted. The PSM analysis showed that survival odds were three times higher for MTx.100 Column-treated patients (95% CI: 1.56-5.88) than for those treated with SOC only.InterpretationThe MTx.100 Column treatment in severe COVID-19 resulted in a lower mortality than SOC by both pre-specified PG and PSM analysis.Trial Registrationclinicaltrials.gov (NCT04358003).
背景在 COVID-19 大流行初期,重症监护室(ICU)收治的重症患者死亡率很高。我们的目的是研究使用 MTx.100 柱吸附血浆是否能提高生存率。方法我们在重症监护室收治的 COVID-19 重症患者中开展了一项前瞻性、单臂、多中心、紧急使用授权(EUA)试验,这些患者在接受标准治疗后病情仍在恶化。主要结果是第28天的全因死亡率。结果分析采用了预先指定的绩效目标 (PG) 和来自最高入组中心的倾向得分匹配 (PSM) 分析,其中患者接受了标准护理 (SOC) 加 MTx.100 治疗。研究结果在 2020 年 5 月 21 日至 2021 年 11 月 2 日期间,美国 7 个中心的 107 名重症 COVID-19 患者(平均年龄 58.1 岁)入组并接受了至少一次血浆吸附治疗。第28天的全因死亡率为37.4%(40/107),比预设的PG值(88.1%,p <0.0001)有所提高。MTx.100 柱或血浆置换术未导致严重不良事件。大多数代谢和炎症指标也有所改善。PSM分析显示,接受MTx.100柱治疗的患者的生存几率(95% CI:1.56-5.88)比仅接受SOC治疗的患者高三倍。
{"title":"Plasma Adsorption with the MTx.100 Column in Critically Ill COVID-19 Patients: A Prospective Study and Propensity Score Analysis","authors":"Christopher Choi, Nicole De Simone, Christopher B. Webb, Peiman Lahsaei, Sean G. Yates, Jay S. Raval, Michelle S. Harkins, Donald J. Hillebrand, Antonio Belli, Nicolas A. Schlapobersky, Tina S. Ipe, Grace C. Banez-Sese, Vikramjit S. Khangoora, Steven D. Nathan, Trudy M. Demko, David C. Young, Sigalit Caron, Ravi Sarode","doi":"10.1177/08850666241280031","DOIUrl":"https://doi.org/10.1177/08850666241280031","url":null,"abstract":"BackgroundEarly in the COVID-19 pandemic, patients with severe disease admitted to the intensive care unit (ICU) had a high incidence of mortality. We aimed to investigate whether plasma adsorption with the MTx.100 Column could improve survival.MethodsWe performed a prospective, single-arm, multicenter, Emergency Use Authorization (EUA) trial in patients admitted to the ICU with severe COVID-19 who were worsening despite standard therapy. The primary outcome was all-cause mortality on day 28. Outcomes were analyzed using both a pre-specified performance goal (PG), and a propensity score-matched (PSM) analysis from the highest enrolling center, in which patients treated with the standard of care (SOC) plus the MTx.100 Column (n = 70) were compared to a contemporaneous cohort treated at the same center with SOC only (n = 244).FindingsBetween May 21, 2020, and November 2, 2021, 107 patients with severe COVID-19 (mean age 58.1) at 7 US centers were enrolled and had at least one plasma adsorption treatment initiated. All-cause mortality on day 28 was 37.4% (40/107), an improvement over the prespecified PG (88.1%, p &lt; 0.0001). There were no serious adverse events attributable to the MTx.100 Column or plasmapheresis. Improvements in most metabolic and inflammatory markers were also noted. The PSM analysis showed that survival odds were three times higher for MTx.100 Column-treated patients (95% CI: 1.56-5.88) than for those treated with SOC only.InterpretationThe MTx.100 Column treatment in severe COVID-19 resulted in a lower mortality than SOC by both pre-specified PG and PSM analysis.Trial Registrationclinicaltrials.gov (NCT04358003).","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":"3 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142251289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Nomogram for Predicting Postoperative Pulmonary Complications in Critical Patients Transferred to ICU After Abdominal Surgery 预测腹部手术后转入重症监护室的危重患者术后肺部并发症的提名图
IF 3.1 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-09-12 DOI: 10.1177/08850666241280900
Bin Wang, Han Sheng Liang, Jia Wei Shen, You Zhong An, Yi Feng
ObjectiveThe purpose of this study was to investigate the risk factors associated with postoperative pulmonary complications(PPCs) in critically ill patients transferred to intensive care unit(ICU) after abdominal surgery and develop a predictive model for this disease.MethodsData for 3716 patients who were admitted to ICU after abdominal surgery in Peking University People's Hospital between January 2015 and December 2020 were retrospectively collected and analyzed to identify the risk factors and develop a nomogram prediction model. Data for patients admitted to ICU following abdominal surgery at Peking University People's Hospital from March 2021 to December 2022 were prospectively collected as a validation set to validate and assess the model.Results10 independent risk factors for PPCs in critically ill patients transferred to ICU after abdominal surgery were identified. A nomogram prediction model was constructed for PPCs in this group patients, the area under ROC curve was 0.771[95%CI: 0.756,0.786] and 0.759[95%CI: 0.726,0.792] in the training set and validation set, respectively.ConclusionsIn this study, independent risk factors for PPCs in critically ill patients transferred to ICU after abdominal surgery were identified. A nomogram prediction model for PPCs in critically ill surgical population was constructed using these factors, demonstrating a good predictive value.
方法 回顾性收集并分析北京大学人民医院2015年1月至2020年12月期间收治的3716例腹部手术后入住ICU患者的数据,以确定风险因素并建立提名图预测模型。结果 在腹部手术后转入ICU的重症患者中,确定了10个导致PPCs的独立危险因素。在训练集和验证集中,ROC 曲线下面积分别为 0.771[95%CI: 0.756,0.786] 和 0.759[95%CI: 0.726,0.792]。利用这些因素构建了重症手术人群 PPCs 的提名图预测模型,并显示出良好的预测价值。
{"title":"A Nomogram for Predicting Postoperative Pulmonary Complications in Critical Patients Transferred to ICU After Abdominal Surgery","authors":"Bin Wang, Han Sheng Liang, Jia Wei Shen, You Zhong An, Yi Feng","doi":"10.1177/08850666241280900","DOIUrl":"https://doi.org/10.1177/08850666241280900","url":null,"abstract":"ObjectiveThe purpose of this study was to investigate the risk factors associated with postoperative pulmonary complications(PPCs) in critically ill patients transferred to intensive care unit(ICU) after abdominal surgery and develop a predictive model for this disease.MethodsData for 3716 patients who were admitted to ICU after abdominal surgery in Peking University People's Hospital between January 2015 and December 2020 were retrospectively collected and analyzed to identify the risk factors and develop a nomogram prediction model. Data for patients admitted to ICU following abdominal surgery at Peking University People's Hospital from March 2021 to December 2022 were prospectively collected as a validation set to validate and assess the model.Results10 independent risk factors for PPCs in critically ill patients transferred to ICU after abdominal surgery were identified. A nomogram prediction model was constructed for PPCs in this group patients, the area under ROC curve was 0.771[95%CI: 0.756,0.786] and 0.759[95%CI: 0.726,0.792] in the training set and validation set, respectively.ConclusionsIn this study, independent risk factors for PPCs in critically ill patients transferred to ICU after abdominal surgery were identified. A nomogram prediction model for PPCs in critically ill surgical population was constructed using these factors, demonstrating a good predictive value.","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":"8 1","pages":"8850666241280900"},"PeriodicalIF":3.1,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142190119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
N-acetyl-cysteine in Intensive Care Unit Patients with Acute Respiratory Distress Syndrome due to COVID-19: A Retrospective Cohort Study. N-乙酰半胱氨酸在 COVID-19 引起的急性呼吸窘迫综合征重症监护室患者中的应用:回顾性队列研究
IF 3.1 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-09-11 DOI: 10.1177/08850666241281281
Diego González-Guzmán,Carlos A Andrade-Castellanos,Marco A Ponce-Gallegos,Ignacio Mesina-Estarrón,José G Mora-Almanza,Hugo E Ruelas-Moreno,Daniel Rodríguez-González,Omar Eguia-Ortega,Luis Enrique Colunga-Lozano
PURPOSEWe assessed the potential association between N-acetyl-cysteine (NAC) and clinical outcomes in critically ill subjects with COVID-19-related ARDS.MATERIAL AND METHODSWe included subjects with confirmed COVID-19 who were admitted to our ICU between March 1, 2020, and January 31, 2021, due to ARDS and necessitating invasive mechanical ventilation (IMV). Subjects who received standard of care (SOC) were compared with subjects who additionally received NAC 600 mg bid orally.RESULTSA total of 243 subjects were included in this study. The results indicate significantly improved survival rates in the NAC plus SOC group, both in the unadjusted analysis and after adjusting for confounding factors such as ARDS severity (HR 0.48, 95% CI 0.32-0.70).CONCLUSIONSWe found that oral administration of NAC was associated with reduced mortality in critically ill patients with COVID-19 related ARDS.
目的我们评估了 N-乙酰-半胱氨酸(NAC)与 COVID-19 相关 ARDS 重症患者临床预后之间的潜在关联。材料和方法我们纳入了 2020 年 3 月 1 日至 2021 年 1 月 31 日期间因 ARDS 而入住重症监护室并需要进行有创机械通气(IMV)的确诊 COVID-19 患者。接受标准护理(SOC)的受试者与额外口服 NAC 600 毫克的受试者进行了比较。结果表明,NAC 加 SOC 组的生存率明显提高,无论是未经调整的分析,还是调整了 ARDS 严重程度等混杂因素后的结果(HR 0.48,95% CI 0.32-0.70)。
{"title":"N-acetyl-cysteine in Intensive Care Unit Patients with Acute Respiratory Distress Syndrome due to COVID-19: A Retrospective Cohort Study.","authors":"Diego González-Guzmán,Carlos A Andrade-Castellanos,Marco A Ponce-Gallegos,Ignacio Mesina-Estarrón,José G Mora-Almanza,Hugo E Ruelas-Moreno,Daniel Rodríguez-González,Omar Eguia-Ortega,Luis Enrique Colunga-Lozano","doi":"10.1177/08850666241281281","DOIUrl":"https://doi.org/10.1177/08850666241281281","url":null,"abstract":"PURPOSEWe assessed the potential association between N-acetyl-cysteine (NAC) and clinical outcomes in critically ill subjects with COVID-19-related ARDS.MATERIAL AND METHODSWe included subjects with confirmed COVID-19 who were admitted to our ICU between March 1, 2020, and January 31, 2021, due to ARDS and necessitating invasive mechanical ventilation (IMV). Subjects who received standard of care (SOC) were compared with subjects who additionally received NAC 600 mg bid orally.RESULTSA total of 243 subjects were included in this study. The results indicate significantly improved survival rates in the NAC plus SOC group, both in the unadjusted analysis and after adjusting for confounding factors such as ARDS severity (HR 0.48, 95% CI 0.32-0.70).CONCLUSIONSWe found that oral administration of NAC was associated with reduced mortality in critically ill patients with COVID-19 related ARDS.","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":"13 1","pages":"8850666241281281"},"PeriodicalIF":3.1,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142190120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Telemedicine Rounding Support for Public Health System Pediatric Intensive Care Units in Brazil can Improve Outcomes. 为巴西公共卫生系统儿科重症监护病房提供远程医疗查房支持可提高疗效。
IF 3 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-09-09 DOI: 10.1177/08850666241268842
Vanessa Cristina Jacovas, Hilda Maria Rodrigues Moleda Constant, Maria Cristina Cotta Matte, Carina Galves Crivella, Maria Eulália Vinadé Chagas, Guilherme Carey Fröhlich, João Ronaldo Mafalda Krauzer, Luciano Remião Guerra, Aristóteles de Almeida Pires, Luciane Gomes da Cunha, Taís de Campos Moreira, Felipe Cezar Cabral

There are discrepancies in resources and expertise available between pediatric intensive care units (PICUs) in Brazil that likely significantly impact the clinical outcomes of patients. The goal of this study was to evaluate the impact of telemedicine rounding support in two public PICUs located in the North and Northeast regions of Brazil. Our intervention involves telehealth rounds connecting two "level II" PICUs with specialist doctors from a hospital of recognized excellence. A before-and-after study was carried out to evaluate telemedicine's impact on PICUs between December 2018 and July 2019. Nine hundred and forty patients were evaluated during this period (426 pre-telemedicine, 514 post-telemedicine). The intervention occurred through telerounds between the command center and the ICUs assisted by telemedicine. In unit A, the implementation of telemedicine reduced the mortality rate from 18.86% to 9.29%, while in unit B, it decreased from 10.76% to 9.72%. There was no change in the median length of stay in unit A, but in unit B, it increased from 6 to 8 days. Logistic regression analysis confirmed a significant reduction in mortality in unit A (odds ratio (OR) 0.50; 95% confidence interval (CI) 0.29-0.86). The study found a positive correlation between adherence to telemedicine recommendations and mortality reduction across both units. This suggests that telemedicine can effectively improve outcomes in PICUs, particularly in regions with limited health-care resources.

巴西的儿科重症监护病房(PICU)在资源和专业技术方面存在差异,这可能会对患者的临床治疗效果产生重大影响。本研究旨在评估远程医疗查房支持对位于巴西北部和东北部地区的两家公立儿科重症监护室的影响。我们的干预措施包括将两个 "二级 "PICU 与一家公认优秀医院的专科医生进行远程医疗查房。我们在 2018 年 12 月至 2019 年 7 月期间开展了一项前后对比研究,以评估远程医疗对 PICU 的影响。在此期间,共对 940 名患者进行了评估(远程医疗前 426 人,远程医疗后 514 人)。在远程医疗的协助下,通过指挥中心和重症监护室之间的远程呼叫进行干预。在 A 病区,远程医疗的实施将死亡率从 18.86% 降至 9.29%,而在 B 病区,死亡率则从 10.76% 降至 9.72%。A 病区的住院时间中位数没有变化,但 B 病区的住院时间中位数从 6 天增加到 8 天。逻辑回归分析证实,A 病区的死亡率显著降低(赔率 (OR) 0.50;95% 置信区间 (CI) 0.29-0.86)。研究发现,在两个病房中,遵守远程医疗建议与死亡率降低之间存在正相关。这表明远程医疗可以有效改善 PICU 的治疗效果,尤其是在医疗资源有限的地区。
{"title":"Telemedicine Rounding Support for Public Health System Pediatric Intensive Care Units in Brazil can Improve Outcomes.","authors":"Vanessa Cristina Jacovas, Hilda Maria Rodrigues Moleda Constant, Maria Cristina Cotta Matte, Carina Galves Crivella, Maria Eulália Vinadé Chagas, Guilherme Carey Fröhlich, João Ronaldo Mafalda Krauzer, Luciano Remião Guerra, Aristóteles de Almeida Pires, Luciane Gomes da Cunha, Taís de Campos Moreira, Felipe Cezar Cabral","doi":"10.1177/08850666241268842","DOIUrl":"https://doi.org/10.1177/08850666241268842","url":null,"abstract":"<p><p>There are discrepancies in resources and expertise available between pediatric intensive care units (PICUs) in Brazil that likely significantly impact the clinical outcomes of patients. The goal of this study was to evaluate the impact of telemedicine rounding support in two public PICUs located in the North and Northeast regions of Brazil. Our intervention involves telehealth rounds connecting two \"level II\" PICUs with specialist doctors from a hospital of recognized excellence. A before-and-after study was carried out to evaluate telemedicine's impact on PICUs between December 2018 and July 2019. Nine hundred and forty patients were evaluated during this period (426 pre-telemedicine, 514 post-telemedicine). The intervention occurred through telerounds between the command center and the ICUs assisted by telemedicine. In unit A, the implementation of telemedicine reduced the mortality rate from 18.86% to 9.29%, while in unit B, it decreased from 10.76% to 9.72%. There was no change in the median length of stay in unit A, but in unit B, it increased from 6 to 8 days. Logistic regression analysis confirmed a significant reduction in mortality in unit A (odds ratio (OR) 0.50; 95% confidence interval (CI) 0.29-0.86). The study found a positive correlation between adherence to telemedicine recommendations and mortality reduction across both units. This suggests that telemedicine can effectively improve outcomes in PICUs, particularly in regions with limited health-care resources.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"8850666241268842"},"PeriodicalIF":3.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers and Strategies to Effective Serious Illness Communication for Patients with End-Stage Liver Disease in the Intensive Care Setting. 在重症监护环境中对终末期肝病患者进行有效重症沟通的障碍和策略。
IF 3 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-09-09 DOI: 10.1177/08850666241280892
Cristal Brown, Saif Khan, Trisha M Parekh, Andrew J Muir, Rebecca L Sudore

Background: Patients with end-stage liver disease (ESLD) often require Intensive Care Unit (ICU) admission during the disease trajectory, but aggressive medical treatment has not resulted in increased quality of life for patients or caregivers. Methods: This narrative review synthesizes relevant data thematically exploring the current state of serious illness communication in the ICU with identification of barriers and potential strategies to improve performance. We provide a conceptual model underscoring the importance of providing comprehensible disease and prognosis knowledge, eliciting patient values and aligning these values with available goals of care options through a series of discussions. Achieving effective serious illness communication supports the delivery of goal concordant care (care aligned with the patient's stated values) and improved quality of life. Results: General barriers to effective serious illness communication include lack of outpatient serious illness communication discussions; formalized provider training, literacy and culturally appropriate patient-directed serious illness communication tools; and unoptimized electronic health records. ESLD-specific barriers to effective serious illness communication include stigma, discussing the uncertainty of prognosis and provider discomfort with serious illness communication. Evidence-based strategies to address general barriers include using the Ask-Tell-Ask communication framework; clinician training to discuss patients' goals and expectations; PREPARE for Your Care literacy and culturally appropriate written and online tools for patients, caregivers, and clinicians; and standardization of documentation in the electronic health record. Evidence-based strategies to address ESLD-specific barriers include practicing with empathy; using the "Best-Case, Worst Case" prognostic framework; and developing interdisciplinary solutions in the ICU. Conclusion: Improving clinician training, providing patients and caregivers easy-to-understand communication tools, standardizing EHR documentation, and improving interdisciplinary communication, including palliative care, may increase goal concordant care and quality of life for critically ill patients with ESLD.

背景:终末期肝病(ESLD)患者在疾病发展过程中往往需要入住重症监护病房(ICU),但积极的药物治疗并不能提高患者或护理人员的生活质量。方法:这篇叙事性综述综合了相关数据,从主题上探讨了重症监护病房重症沟通的现状,并指出了改善沟通的障碍和潜在策略。我们提供了一个概念模型,强调了提供可理解的疾病和预后知识、激发患者的价值观并通过一系列讨论使这些价值观与现有的护理目标相一致的重要性。实现有效的重症沟通有助于提供目标一致的护理(与患者所述价值观一致的护理)和提高生活质量。结果:阻碍有效重症沟通的一般障碍包括:缺乏门诊重症沟通讨论;医疗服务提供者缺乏正规培训、文化知识和适合患者文化的重症沟通工具;以及电子健康记录未优化。ESLD对有效重病沟通的特定障碍包括耻辱感、讨论预后的不确定性以及医疗服务提供者对重病沟通的不适应。解决一般障碍的循证策略包括:使用 "问-说-问 "沟通框架;对临床医生进行培训,以讨论患者的目标和期望;为患者、护理人员和临床医生提供 "为您的护理做好准备 "扫盲和文化适宜的书面及在线工具;以及电子健康记录文档的标准化。解决 ESLD 特定障碍的循证策略包括:换位思考;使用 "最好的情况,最坏的情况 "预后框架;在重症监护室制定跨学科解决方案。结论加强对临床医生的培训、为患者和护理人员提供易于理解的沟通工具、规范电子病历记录以及改善跨学科沟通(包括姑息治疗),可以提高 ESLD 重症患者的护理目标一致性和生活质量。
{"title":"Barriers and Strategies to Effective Serious Illness Communication for Patients with End-Stage Liver Disease in the Intensive Care Setting.","authors":"Cristal Brown, Saif Khan, Trisha M Parekh, Andrew J Muir, Rebecca L Sudore","doi":"10.1177/08850666241280892","DOIUrl":"10.1177/08850666241280892","url":null,"abstract":"<p><p><b>Background:</b> Patients with end-stage liver disease (ESLD) often require Intensive Care Unit (ICU) admission during the disease trajectory, but aggressive medical treatment has not resulted in increased quality of life for patients or caregivers. <b>Methods:</b> This narrative review synthesizes relevant data thematically exploring the current state of serious illness communication in the ICU with identification of barriers and potential strategies to improve performance. We provide a conceptual model underscoring the importance of providing comprehensible disease and prognosis knowledge, eliciting patient values and aligning these values with available goals of care options through a series of discussions. Achieving effective serious illness communication supports the delivery of goal concordant care (care aligned with the patient's stated values) and improved quality of life. <b>Results:</b> General barriers to effective serious illness communication include lack of outpatient serious illness communication discussions; formalized provider training, literacy and culturally appropriate patient-directed serious illness communication tools; and unoptimized electronic health records. ESLD-specific barriers to effective serious illness communication include stigma, discussing the uncertainty of prognosis and provider discomfort with serious illness communication. Evidence-based strategies to address general barriers include using the Ask-Tell-Ask communication framework; clinician training to discuss patients' goals and expectations; PREPARE for Your Care literacy and culturally appropriate written and online tools for patients, caregivers, and clinicians; and standardization of documentation in the electronic health record. Evidence-based strategies to address ESLD-specific barriers include practicing with empathy; using the \"Best-Case, Worst Case\" prognostic framework; and developing interdisciplinary solutions in the ICU. <b>Conclusion:</b> Improving clinician training, providing patients and caregivers easy-to-understand communication tools, standardizing EHR documentation, and improving interdisciplinary communication, including palliative care, may increase goal concordant care and quality of life for critically ill patients with ESLD.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"8850666241280892"},"PeriodicalIF":3.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Mortality in Sepsis-Associated Acute Respiratory Distress Syndrome: A Machine Learning Approach Using the MIMIC-III Database. 预测败血症相关急性呼吸窘迫综合征的死亡率:使用 MIMIC-III 数据库的机器学习方法。
IF 3 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-09-05 DOI: 10.1177/08850666241281060
Shengtian Mu, Dongli Yan, Jie Tang, Zhen Zheng

Background: To develop and validate a mortality prediction model for patients with sepsis-associated Acute Respiratory Distress Syndrome (ARDS).

Methods: This retrospective cohort study included 2466 patients diagnosed with sepsis and ARDS within 24 h of ICU admission. Demographic, clinical, and laboratory parameters were extracted from Medical Information Mart for Intensive Care III (MIMIC-III) database. Feature selection was performed using the Boruta algorithm, followed by the construction of seven ML models: logistic regression, Naive Bayes, k-nearest neighbor, support vector machine, decision tree, Random Forest, and extreme gradient boosting. Model performance was evaluated using the area under the receiver operating characteristic curve, accuracy, sensitivity, specificity, positive predictive value, and negative predictive value.

Results: The study identified 24 variables significantly associated with mortality. The optimal ML model, a Random Forest model, demonstrated an AUC of 0.8015 in the test set, with high accuracy and specificity. The model highlighted the importance of blood urea nitrogen, age, urine output, Simplified Acute Physiology Score II, and albumin levels in predicting mortality.

Conclusions: The model's superior predictive performance underscores the potential for integrating advanced analytics into clinical decision-making processes, potentially improving patient outcomes and resource allocation in critical care settings.

背景:开发并验证脓毒症相关急性呼吸窘迫综合征(ARDS)患者死亡率预测模型:开发并验证脓毒症相关急性呼吸窘迫综合征(ARDS)患者的死亡率预测模型:这项回顾性队列研究纳入了 2466 名在入住重症监护室 24 小时内被诊断为脓毒症和 ARDS 的患者。研究人员从重症监护医学信息市场 III(MIMIC-III)数据库中提取了人口统计学、临床和实验室参数。使用 Boruta 算法进行特征选择,然后构建了七个多重多重模型:逻辑回归、Naive Bayes、k-近邻、支持向量机、决策树、随机森林和极端梯度提升。使用接收者操作特征曲线下面积、准确性、灵敏度、特异性、阳性预测值和阴性预测值对模型性能进行评估:结果:研究发现了 24 个与死亡率明显相关的变量。最佳的 ML 模型(随机森林模型)在测试集中的 AUC 为 0.8015,具有较高的准确性和特异性。该模型强调了血尿素氮、年龄、尿量、简化急性生理学评分 II 和白蛋白水平在预测死亡率方面的重要性:该模型卓越的预测性能凸显了将高级分析技术整合到临床决策过程中的潜力,有可能改善重症监护环境中的患者预后和资源分配。
{"title":"Predicting Mortality in Sepsis-Associated Acute Respiratory Distress Syndrome: A Machine Learning Approach Using the MIMIC-III Database.","authors":"Shengtian Mu, Dongli Yan, Jie Tang, Zhen Zheng","doi":"10.1177/08850666241281060","DOIUrl":"https://doi.org/10.1177/08850666241281060","url":null,"abstract":"<p><strong>Background: </strong>To develop and validate a mortality prediction model for patients with sepsis-associated Acute Respiratory Distress Syndrome (ARDS).</p><p><strong>Methods: </strong>This retrospective cohort study included 2466 patients diagnosed with sepsis and ARDS within 24 h of ICU admission. Demographic, clinical, and laboratory parameters were extracted from Medical Information Mart for Intensive Care III (MIMIC-III) database. Feature selection was performed using the Boruta algorithm, followed by the construction of seven ML models: logistic regression, Naive Bayes, k-nearest neighbor, support vector machine, decision tree, Random Forest, and extreme gradient boosting. Model performance was evaluated using the area under the receiver operating characteristic curve, accuracy, sensitivity, specificity, positive predictive value, and negative predictive value.</p><p><strong>Results: </strong>The study identified 24 variables significantly associated with mortality. The optimal ML model, a Random Forest model, demonstrated an AUC of 0.8015 in the test set, with high accuracy and specificity. The model highlighted the importance of blood urea nitrogen, age, urine output, Simplified Acute Physiology Score II, and albumin levels in predicting mortality.</p><p><strong>Conclusions: </strong>The model's superior predictive performance underscores the potential for integrating advanced analytics into clinical decision-making processes, potentially improving patient outcomes and resource allocation in critical care settings.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"8850666241281060"},"PeriodicalIF":3.0,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Sepsis-Related Medical Emergency Team (MET) Calls with Pharmacist Involvement and Time to Antimicrobial Administration. 评估有药剂师参与的败血症相关医疗急救小组 (MET) 呼叫和抗菌药物给药时间。
IF 3 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-09-05 DOI: 10.1177/08850666241277507
Li Xian Simon Du, Gail Emily Edwards, Zohal Rashidzada, Harvey Newnham, Steve McGloughlin, Judit Orosz, Erica Y Tong

Objective: To evaluate the difference in proportion of patients receiving antimicrobials within one hour of sepsis recognition at sepsis-related Medical Emergency Team (MET) calls, without or with a sepsis-credentialed pharmacist. Design: Retrospective pre and post-intervention study. Setting: Single centre tertiary referral hospital. Participants: Patients admitted to the General Medicine Unit who had a sepsis-related MET call 24 hrs per day, and all other units from 17:00-08:00 hrs from August 2019 to Jan 2020 in the pre-intervention cohort and Aug 2020 to Jan 2021 for the post-intervention cohort. Interventions: Pharmacists attended MET calls to assist selection of antimicrobials, collaboratively prescribe with the medical officers, ensure supply, provide advice on dosing calculations, reconstitution, and administration. The pre-intervention cohort (Aug 2019-Jan 2020) did not have credentialed pharmacists' involvement at MET calls. Outcome Measures: Proportion of patients who received antimicrobials within one hours of MET call. Results: There were 97 sepsis-related MET calls in the pre-intervention cohort and 110 sepsis-related MET calls in the post-intervention cohort. A significantly higher proportion of patients received antimicrobials within one hour with pharmacist involvement, compared to control (81.3% vs 59.7%, P = .0006). A reduction in median time to antimicrobial administration (43 min vs 54 min, P = .017) was observed. Conclusion: Sepsis-related MET calls with pharmacist involvement experienced a greater proportion of patients receiving antimicrobials within one hour of sepsis recognition, and a reduction in median time to antimicrobial administration. These results provide support for routine pharmacist involvement at MET calls to assist patients receiving medications in a timely and efficient manner.

目的评估在没有脓毒症认证药剂师或有脓毒症认证药剂师的情况下,脓毒症相关医疗急救小组 (MET) 在确认脓毒症后一小时内接受抗菌药物治疗的患者比例差异。设计:干预前后的回顾性研究。地点:单中心三级转诊医院单中心三级转诊医院。参与者:2019年8月至2020年1月干预前队列和2020年8月至2021年1月干预后队列中每天24小时有脓毒症相关MET呼叫的普通内科病房住院患者,以及17:00-08:00期间所有其他病房的住院患者。干预措施:药剂师参加 MET 电话会议,协助选择抗菌药物,与医务人员合作开具处方,确保供应,并就剂量计算、复方和给药提供建议。干预前队列(2019 年 8 月至 2020 年 1 月)中没有经过认证的药剂师参与 MET 电话会议。结果测量:在 MET 呼叫后一小时内获得抗菌药物的患者比例。结果干预前队列中有 97 次与败血症相关的 MET 呼叫,干预后队列中有 110 次与败血症相关的 MET 呼叫。与对照组相比,有药剂师参与的患者在一小时内获得抗菌药物的比例明显更高(81.3% vs 59.7%,P = .0006)。抗菌药物给药的中位时间也有所缩短(43 分钟 vs 54 分钟,P = .017)。结论:在有药剂师参与的脓毒症相关 MET 呼叫中,脓毒症识别后一小时内接受抗菌药物治疗的患者比例更高,抗菌药物治疗的中位时间也有所缩短。这些结果支持药剂师在 MET 呼叫中的常规参与,以帮助患者及时、高效地接受药物治疗。
{"title":"Evaluation of Sepsis-Related Medical Emergency Team (MET) Calls with Pharmacist Involvement and Time to Antimicrobial Administration.","authors":"Li Xian Simon Du, Gail Emily Edwards, Zohal Rashidzada, Harvey Newnham, Steve McGloughlin, Judit Orosz, Erica Y Tong","doi":"10.1177/08850666241277507","DOIUrl":"https://doi.org/10.1177/08850666241277507","url":null,"abstract":"<p><p><b>Objective:</b> To evaluate the difference in proportion of patients receiving antimicrobials within one hour of sepsis recognition at sepsis-related Medical Emergency Team (MET) calls, without or with a sepsis-credentialed pharmacist. <b>Design:</b> Retrospective pre and post-intervention study. <b>Setting:</b> Single centre tertiary referral hospital. <b>Participants:</b> Patients admitted to the General Medicine Unit who had a sepsis-related MET call 24 hrs per day, and all other units from 17:00-08:00 hrs from August 2019 to Jan 2020 in the pre-intervention cohort and Aug 2020 to Jan 2021 for the post-intervention cohort. <b>Interventions:</b> Pharmacists attended MET calls to assist selection of antimicrobials, collaboratively prescribe with the medical officers, ensure supply, provide advice on dosing calculations, reconstitution, and administration. The pre-intervention cohort (Aug 2019-Jan 2020) did not have credentialed pharmacists' involvement at MET calls. <b>Outcome Measures:</b> Proportion of patients who received antimicrobials within one hours of MET call. <b>Results:</b> There were 97 sepsis-related MET calls in the pre-intervention cohort and 110 sepsis-related MET calls in the post-intervention cohort. A significantly higher proportion of patients received antimicrobials within one hour with pharmacist involvement, compared to control (81.3% vs 59.7%, <i>P</i> = .0006). A reduction in median time to antimicrobial administration (43 min vs 54 min, <i>P</i> = .017) was observed. <b>Conclusion:</b> Sepsis-related MET calls with pharmacist involvement experienced a greater proportion of patients receiving antimicrobials within one hour of sepsis recognition, and a reduction in median time to antimicrobial administration. These results provide support for routine pharmacist involvement at MET calls to assist patients receiving medications in a timely and efficient manner.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"8850666241277507"},"PeriodicalIF":3.0,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nephrotoxic Risk Associated With Combination Therapy of Vancomycin and Piperacillin-Tazobactam in Critically Ill Patients With Chronic Kidney Disease. 重症慢性肾病患者接受万古霉素和哌拉西林-他唑巴坦联合疗法的肾毒性风险
IF 3 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-09-01 Epub Date: 2024-02-28 DOI: 10.1177/08850666241234577
Tamyah Pipkin, Stuart Pope, Alley Killian, Sarah Green, Benjamin Albrecht, Katherine Nugent

Background: The combination of vancomycin and piperacillin-tazobactam (VPT) has been associated with acute kidney injury (AKI) in hospitalized patients when compared to similar combinations. Additional studies examining this nephrotoxic risk in critically ill patients have not consistently demonstrated the aforementioned association. Furthermore, patients with baseline renal dysfunction have been excluded from almost all of these studies, creating a need to examine the risk in this patient population. Methods: This was a retrospective cohort analysis of critically ill adults with baseline chronic kidney disease (CKD) who received vancomycin plus an anti-pseudomonal beta-lactam at Emory University Hospital. The primary outcome was incidence of AKI. Secondary outcomes included stage of AKI, time to development of AKI, time to return to baseline renal function, new requirement for renal replacement therapy, intensive care unit and hospital length of stay, and in-hospital mortality. Results: A total of 109 patients were included. There was no difference observed in the primary outcome between the VPT (50%) and comparator (58%) group (P = .4), stage 2 or 3 AKI (15.9% vs 6%; P = .98), time to AKI development (1.7 vs 2 days; P = .5), time to return to baseline renal function (4 vs 3 days; P = .2), new requirement for RRT (4.5% vs 1.5%; P = .3), ICU length of stay (7.3 vs 7.4 days; P = .9), hospital length of stay (19.3 vs 20.1 days; P = .87), or in-hospital mortality (15.9% vs 10.8%; P = .4). A significant difference was observed in the duration of antibiotic exposure (3.32 vs 2.62 days; P = .045 days). Conclusion: VPT was not associated with an increased risk of AKI or adverse renal outcomes. Our findings suggest that the use of this antibiotic combination should not be avoided in this patient population. More robust prospective studies are warranted to confirm these findings.

背景:在住院患者中,万古霉素和哌拉西林-他唑巴坦(VPT)的组合与类似组合相比,与急性肾损伤(AKI)有关。针对危重病人肾毒性风险的其他研究并未一致证明上述关联。此外,几乎所有这些研究都排除了基线肾功能不全的患者,因此有必要对这部分患者的风险进行研究。研究方法这是一项回顾性队列分析,研究对象是埃默里大学医院接受万古霉素加抗假丝酵母β-内酰胺治疗的重症成人慢性肾病(CKD)患者。主要结果是AKI的发生率。次要结果包括 AKI 分期、发生 AKI 的时间、恢复基线肾功能的时间、肾脏替代治疗的新需求、重症监护室和住院时间以及院内死亡率。结果:共纳入了 109 名患者。在 VPT 组(50%)和对比组(58%)的主要结果(P = .4)、2 期或 3 期 AKI(15.9% vs 6%;P = .98)、发生 AKI 的时间(1.7 vs 2 天;P = .5)、恢复基线肾功能的时间(4 vs 3 天;P = .2)、新的 RRT 需求(4.5% vs 1.5%;P = .3)、ICU 住院时间(7.3 vs 7.4 天;P = .9)、住院时间(19.3 vs 20.1 天;P = .87)或院内死亡率(15.9% vs 10.8%;P = .4)。在抗生素暴露时间方面也有明显差异(3.32 天 vs 2.62 天;P = .045 天)。结论VPT 与 AKI 或不良肾功能结果风险增加无关。我们的研究结果表明,在这类患者中不应避免使用这种抗生素组合。有必要进行更有力的前瞻性研究来证实这些发现。
{"title":"Nephrotoxic Risk Associated With Combination Therapy of Vancomycin and Piperacillin-Tazobactam in Critically Ill Patients With Chronic Kidney Disease.","authors":"Tamyah Pipkin, Stuart Pope, Alley Killian, Sarah Green, Benjamin Albrecht, Katherine Nugent","doi":"10.1177/08850666241234577","DOIUrl":"10.1177/08850666241234577","url":null,"abstract":"<p><p><b>Background:</b> The combination of vancomycin and piperacillin-tazobactam (VPT) has been associated with acute kidney injury (AKI) in hospitalized patients when compared to similar combinations. Additional studies examining this nephrotoxic risk in critically ill patients have not consistently demonstrated the aforementioned association. Furthermore, patients with baseline renal dysfunction have been excluded from almost all of these studies, creating a need to examine the risk in this patient population. <b>Methods:</b> This was a retrospective cohort analysis of critically ill adults with baseline chronic kidney disease (CKD) who received vancomycin plus an anti-pseudomonal beta-lactam at Emory University Hospital. The primary outcome was incidence of AKI. Secondary outcomes included stage of AKI, time to development of AKI, time to return to baseline renal function, new requirement for renal replacement therapy, intensive care unit and hospital length of stay, and in-hospital mortality. <b>Results:</b> A total of 109 patients were included. There was no difference observed in the primary outcome between the VPT (50%) and comparator (58%) group (<i>P</i> = .4), stage 2 or 3 AKI (15.9% vs 6%; <i>P</i> = .98), time to AKI development (1.7 vs 2 days; <i>P</i> = .5), time to return to baseline renal function (4 vs 3 days; <i>P</i> = .2), new requirement for RRT (4.5% vs 1.5%; <i>P</i> = .3), ICU length of stay (7.3 vs 7.4 days; <i>P</i> = .9), hospital length of stay (19.3 vs 20.1 days; <i>P</i> = .87), or in-hospital mortality (15.9% vs 10.8%; <i>P</i> = .4). A significant difference was observed in the duration of antibiotic exposure (3.32 vs 2.62 days; <i>P</i> = .045 days). <b>Conclusion:</b> VPT was not associated with an increased risk of AKI or adverse renal outcomes. Our findings suggest that the use of this antibiotic combination should not be avoided in this patient population. More robust prospective studies are warranted to confirm these findings.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"860-865"},"PeriodicalIF":3.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139983128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuous Versus Intermittent Control Cuff Pressure for Preventing Ventilator-Associated Pneumonia: An Updated Meta-Analysis. 持续与间歇控制袖带压力预防呼吸机相关肺炎:最新的 Meta 分析。
IF 3 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-09-01 Epub Date: 2024-02-19 DOI: 10.1177/08850666241232369
Yanshuo Wu, Yanan Li, Meirong Sun, Jingjing Bu, Congcong Zhao, Zhenjie Hu, Yanling Yin

Objective: This study aimed to evaluate the effect of continuous control cuff pressure (CCCP) versus intermittent control cuff pressure (ICCP) for the prevention of ventilator-associated pneumonia (VAP) in critically ill patients.

Methods: Relevant literature was searched in several databases, including PubMed, Embase, Web of Science, ProQuest, the Cochrane Library, Wanfang Database and China National Knowledge Infrastructure between inception and September 2022. Randomized controlled trials were considered eligible if they compared CCCP with ICCP for the prevention of VAP in critically ill patients. This meta-analysis was performed using the RevMan 5.3 and Trial Sequential Analysis 0.9 software packages. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework was used to assess the level of evidence.

Results: We identified 14 randomized control trials with a total of 2080 patients. Meta-analysis revealed that CCCP was associated with a significantly lower incidence of VAP compared with ICCP (relative risk [RR] = 0.52; 95% confidence interval [CI]: 0.37-0.74; P < 0.001), although considerable heterogeneity was observed (I2 = 71%). Conducting trial sequential analysis confirmed the finding, and the GRADE level was moderate. Subgroup analysis demonstrated that CCCP combined with subglottic secretion drainage (SSD) had a more significant effect on reducing VAP (RR = 0.39; 95% CI = 0.29-0.52; P < 0.001). The effect of CCCP on ventilator-associated respiratory infection (VARI) incidence was uncertain (RR = 0.81; 95% CI = 0.53-1.24; P = 0.34; I2 = 61%). Additionally, CCCP significantly reduced the duration of mechanical ventilation (MV) (mean difference [MD] = -2.42 days; 95% CI = -4.71-0.12; P = 0.04; I2 = 87%). Descriptive analysis showed that CCCP improved the qualified rate of cuff pressure. However, no significant differences were found in the length of intensive care unit (ICU) stay (MD = 2.42 days; 95% CI = -1.84-6.68; P = 0.27) and ICU mortality (RR = 0.86; 95% CI = 0.74-1.00; P = 0.05).

Conclusion: Our findings suggest that the combination of CCCP and SSD can reduce the incidence of VAP and the duration of MV and maintain the stability of cuff pressure. A combination of CCCP and SSD applications is suggested for preventing VAP.

研究目的本研究旨在评估持续控制袖带压力(CCCP)与间歇控制袖带压力(ICCP)在重症患者中预防呼吸机相关肺炎(VAP)的效果:在多个数据库中检索了相关文献,包括PubMed、Embase、Web of Science、ProQuest、Cochrane图书馆、万方数据库和中国国家知识基础设施,检索时间从开始到2022年9月。如果随机对照试验对 CCCP 和 ICCP 预防重症患者 VAP 进行了比较,则符合条件。本荟萃分析使用 RevMan 5.3 和 Trial Sequential Analysis 0.9 软件包进行。采用建议评估、发展和评价分级(GRADE)框架评估证据水平:结果:我们确定了 14 项随机对照试验,共计 2080 名患者。Meta 分析显示,与 ICCP 相比,CCCP 的 VAP 发生率明显较低(相对风险 [RR] = 0.52;95% 置信区间 [CI]:0.37-0.74;P<0.05):0.37-0.74; P i2 = 71%)。进行试验序列分析证实了这一结果,GRADE等级为中度。亚组分析表明,CCCP 联合声门下分泌物引流术(SSD)对减少 VAP 有更显著的效果(RR = 0.39;95% CI = 0.29-0.52;P P = 0.34;I2 = 61%)。此外,CCCP 还能显著缩短机械通气(MV)时间(平均差 [MD] = -2.42天;95% CI = -4.71-0.12;P = 0.04;I2 = 87%)。描述性分析表明,CCCP 提高了袖带压力的合格率。然而,在重症监护室(ICU)住院时间(MD = 2.42 天;95% CI = -1.84-6.68; P = 0.27)和 ICU 死亡率(RR = 0.86; 95% CI = 0.74-1.00; P = 0.05)方面没有发现明显差异:我们的研究结果表明,联合使用 CCCP 和 SSD 可以降低 VAP 的发生率,缩短 MV 的持续时间,并保持袖带压力的稳定性。建议联合应用 CCCP 和 SSD 预防 VAP。
{"title":"Continuous Versus Intermittent Control Cuff Pressure for Preventing Ventilator-Associated Pneumonia: An Updated Meta-Analysis.","authors":"Yanshuo Wu, Yanan Li, Meirong Sun, Jingjing Bu, Congcong Zhao, Zhenjie Hu, Yanling Yin","doi":"10.1177/08850666241232369","DOIUrl":"10.1177/08850666241232369","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the effect of continuous control cuff pressure (CCCP) versus intermittent control cuff pressure (ICCP) for the prevention of ventilator-associated pneumonia (VAP) in critically ill patients.</p><p><strong>Methods: </strong>Relevant literature was searched in several databases, including PubMed, Embase, Web of Science, ProQuest, the Cochrane Library, Wanfang Database and China National Knowledge Infrastructure between inception and September 2022. Randomized controlled trials were considered eligible if they compared CCCP with ICCP for the prevention of VAP in critically ill patients. This meta-analysis was performed using the RevMan 5.3 and Trial Sequential Analysis 0.9 software packages. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework was used to assess the level of evidence.</p><p><strong>Results: </strong>We identified 14 randomized control trials with a total of 2080 patients. Meta-analysis revealed that CCCP was associated with a significantly lower incidence of VAP compared with ICCP (relative risk [RR] = 0.52; 95% confidence interval [CI]: 0.37-0.74; <i>P</i> < 0.001), although considerable heterogeneity was observed (<i>I</i><sup>2</sup> = 71%). Conducting trial sequential analysis confirmed the finding, and the GRADE level was moderate. Subgroup analysis demonstrated that CCCP combined with subglottic secretion drainage (SSD) had a more significant effect on reducing VAP (RR = 0.39; 95% CI = 0.29-0.52; <i>P</i> < 0.001). The effect of CCCP on ventilator-associated respiratory infection (VARI) incidence was uncertain (RR = 0.81; 95% CI = 0.53-1.24; <i>P</i> = 0.34; <i>I</i><sup>2</sup> = 61%). Additionally, CCCP significantly reduced the duration of mechanical ventilation (MV) (mean difference [MD] = -2.42 days; 95% CI = -4.71-0.12; <i>P</i> = 0.04; <i>I</i><sup>2</sup> = 87%). Descriptive analysis showed that CCCP improved the qualified rate of cuff pressure. However, no significant differences were found in the length of intensive care unit (ICU) stay (MD = 2.42 days; 95% CI = -1.84-6.68; <i>P</i> = 0.27) and ICU mortality (RR = 0.86; 95% CI = 0.74-1.00; <i>P</i> = 0.05).</p><p><strong>Conclusion: </strong>Our findings suggest that the combination of CCCP and SSD can reduce the incidence of VAP and the duration of MV and maintain the stability of cuff pressure. A combination of CCCP and SSD applications is suggested for preventing VAP.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"829-839"},"PeriodicalIF":3.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139905834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Shock Indices with Peri-Intubation Hypotension and Other Outcomes: A Sub-Study of the KEEP PACE Trial. 休克指数与插管前低血压及其他结果的关系:KEEP PACE 试验的一项子研究。
IF 3 3区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-09-01 Epub Date: 2024-02-25 DOI: 10.1177/08850666241235591
Nathan J Smischney, Mohamed O Seisa, Darrell R Schroeder

Background: Based on current evidence, there appears to be an association between peri-intubation hypotension and patient morbidity and mortality. Studies have identified shock indices as possible pre-intubation risk factors for peri-intubation hypotension. Thus, we sought to evaluate the association between shock index (SI), modified shock index (MSI), and diastolic shock index (DSI) and peri-intubation hypotension along with other outcomes.

Methods: The present study is a sub-study of a randomized controlled trial involving critically ill patients undergoing intubation. We defined peri-intubation hypotension as a decrease in mean arterial pressure <65 mm Hg and/or a reduction of 40% from baseline; or the initiation of, or increase in infusion dosage of, any vasopressor medication (bolus or infusion) during the 30-min period following intubation. SI, MSI, and DSI were analyzed as continuous variables and categorically using pre-established cut-offs. We also explored the effect of age on shock indices.

Results: A total of 151 patients were included in the analysis. Mean pre-intubation SI was 1.0  ±  0.3, MSI 1.5  ±  0.5, and DSI 1.9  ±  0.7. Increasing SI, MSI, and DSI were significantly associated with peri-intubation hypotension (OR [95% CI] per 0.1 increase  =  1.16 [1.04, 1.30], P  =  .009 for SI; 1.14 [1.05, 1.24], P  =  .003 for MSI; and 1.11 [1.04, 1.19], P  =  .003 for DSI). The area under the ROC curves did not differ across shock indices (0.66 vs 0.67 vs 0.69 for SI, MSI, and DSI respectively; P  =  .586). Increasing SI, MSI, and DSI were significantly associated with worse sequential organ failure assessment (SOFA) score (spearman rank correlation: r  =  0.30, r  =  0.40, and r  =  0.45 for SI, MSI, and DSI, respectively, all P < .001) but not with other outcomes. There was no significant impact when incorporating age.

Conclusions: Increasing SI, MSI, and DSI were all significantly associated with peri-intubation hypotension and worse SOFA scores but not with other outcomes. Shock indices remain a useful bedside tool to assess the potential likelihood of peri-intubation hypotension.

Trial registration: ClinicalTrials.gov identifier - NCT02105415.

背景:根据目前的证据,插管周围低血压似乎与患者的发病率和死亡率有关。研究发现,插管前休克指数可能是导致插管周围低血压的风险因素。因此,我们试图评估休克指数(SI)、修正休克指数(MSI)和舒张休克指数(DSI)与插管周围低血压及其他结果之间的关联:本研究是一项随机对照试验的子研究,涉及接受插管治疗的重症患者。我们将插管周围低血压定义为平均动脉压下降:共有 151 名患者纳入分析。插管前平均 SI 为 1.0 ± 0.3,MSI 为 1.5 ± 0.5,DSI 为 1.9 ± 0.7。SI、MSI 和 DSI 的增加与围插管期低血压显著相关(每增加 0.1 的 OR [95% CI] = 1.16 [1.04, 1.30],SI=0.009;MSI=1.14 [1.05, 1.24],P=0.003;DSI=1.11 [1.04, 1.19],P=0.003)。不同冲击指数的 ROC 曲线下面积没有差异(SI、MSI 和 DSI 分别为 0.66 vs 0.67 vs 0.69;P = .586)。SI、MSI 和 DSI 的增加均与插管周围低血压和 SOFA 评分恶化有显著相关性,但与其他结果无关。冲击指数仍是评估插管周围低血压潜在可能性的有用床旁工具:试验注册:ClinicalTrials.gov identifier - NCT02105415。
{"title":"Association of Shock Indices with Peri-Intubation Hypotension and Other Outcomes: A Sub-Study of the KEEP PACE Trial.","authors":"Nathan J Smischney, Mohamed O Seisa, Darrell R Schroeder","doi":"10.1177/08850666241235591","DOIUrl":"10.1177/08850666241235591","url":null,"abstract":"<p><strong>Background: </strong>Based on current evidence, there appears to be an association between peri-intubation hypotension and patient morbidity and mortality. Studies have identified shock indices as possible pre-intubation risk factors for peri-intubation hypotension. Thus, we sought to evaluate the association between shock index (SI), modified shock index (MSI), and diastolic shock index (DSI) and peri-intubation hypotension along with other outcomes.</p><p><strong>Methods: </strong>The present study is a sub-study of a randomized controlled trial involving critically ill patients undergoing intubation. We defined peri-intubation hypotension as a decrease in mean arterial pressure <65 mm Hg and/or a reduction of 40% from baseline; or the initiation of, or increase in infusion dosage of, any vasopressor medication (bolus or infusion) during the 30-min period following intubation. SI, MSI, and DSI were analyzed as continuous variables and categorically using pre-established cut-offs. We also explored the effect of age on shock indices.</p><p><strong>Results: </strong>A total of 151 patients were included in the analysis. Mean pre-intubation SI was 1.0  ±  0.3, MSI 1.5  ±  0.5, and DSI 1.9  ±  0.7. Increasing SI, MSI, and DSI were significantly associated with peri-intubation hypotension (OR [95% CI] per 0.1 increase  =  1.16 [1.04, 1.30], <i>P</i>  =  .009 for SI; 1.14 [1.05, 1.24], <i>P</i>  =  .003 for MSI; and 1.11 [1.04, 1.19], <i>P</i>  =  .003 for DSI). The area under the ROC curves did not differ across shock indices (0.66 vs 0.67 vs 0.69 for SI, MSI, and DSI respectively; <i>P</i>  =  .586). Increasing SI, MSI, and DSI were significantly associated with worse sequential organ failure assessment (SOFA) score (spearman rank correlation: r  =  0.30, r  =  0.40, and r  =  0.45 for SI, MSI, and DSI, respectively, all <i>P</i> < .001) but not with other outcomes. There was no significant impact when incorporating age.</p><p><strong>Conclusions: </strong>Increasing SI, MSI, and DSI were all significantly associated with peri-intubation hypotension and worse SOFA scores but not with other outcomes. Shock indices remain a useful bedside tool to assess the potential likelihood of peri-intubation hypotension.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov identifier - NCT02105415.</p>","PeriodicalId":16307,"journal":{"name":"Journal of Intensive Care Medicine","volume":" ","pages":"866-874"},"PeriodicalIF":3.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139972166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Intensive Care Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1